These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 17340999)

  • 1. [Nosopharyngeal microflora in ambulatory treated children and adults with upper respiratory tract infections].
    Zientara M; Rudy M; Nowakowska M; Martirosian G
    Med Dosw Mikrobiol; 2006; 58(3):239-45. PubMed ID: 17340999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
    Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R
    Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART Clinic of Felegehiwot Referral Hospital, Ethiopia.
    Mulu W; Yizengaw E; Alemu M; Mekonnen D; Hailu D; Ketemaw K; Abera B; Kibret M
    PLoS One; 2018; 13(5):e0196722. PubMed ID: 29746496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.
    Sahm DF; Brown NP; Draghi DC; Evangelista AT; Yee YC; Thornsberry C
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):8-15. PubMed ID: 18931466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
    Sahm DF; Brown NP; Thornsberry C; Jones ME
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 12. [The penicillin susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus in persons suffering from upper respiratory tract infections].
    Hareńska K; Janicka G; Wojciechowska D
    Przegl Epidemiol; 1998; 52(1-2):199-203. PubMed ID: 9738431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
    Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010].
    Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.
    Doern GV
    Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S17-23. PubMed ID: 12511856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2005 and 2006.
    Gomi K; Watanabe A; Aoki S; Kikuchi T; Fuse K; Nukiwa T; Kurokawa I; Fujimura S
    Int J Antimicrob Agents; 2007 May; 29(5):586-92. PubMed ID: 17387003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey.
    Gonullu N; Catal F; Kucukbasmaci O; Ozdemir S; Torun MM; Berkiten R
    Chemotherapy; 2009; 55(3):161-7. PubMed ID: 19390189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.